ADC Therapeutics SA — Form 6-K
Reporting period: Form 6-K filed December 14, 2020, for the month of December 2020. ADC Therapeutics SA is a Swiss foreign private issuer and indicates that it files annual reports on Form 20-F.
Filing contents
The filing contains the cover page, signature, and an exhibit index identifying Exhibit 99.1 as a press release dated December 14, 2020. The text provided does not include the press release itself.
Financial and operating information
- The filing text does not provide clear values for revenue, profit or loss, cash flow, margins, debt, liquidity, operating results, or other financial metrics.
- No material changes versus a prior comparable period are described in the provided text.
Guidance, outlook, risks, and unusual items
The provided filing text does not contain guidance, management commentary, risk disclosures, contingencies, or unusual items. These matters may be addressed in the referenced Exhibit 99.1 press release, which is not included.
Investor verification items
- Obtain and review Exhibit 99.1, the December 14, 2020 press release.
- Verify whether the press release contains financial results, clinical or regulatory updates, financing information, guidance, or material risk disclosures.
- Confirm any reported figures and management commentary against the company’s related SEC filings and Form 20-F disclosures.